α- and β-secretase:: profound changes in Alzheimer's disease

被引:152
|
作者
Tyler, SJ
Dawbarn, D
Wilcock, GK
Allen, SJ [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Mol Neurobiol Unit, URCN Care Elderly, Bristol BS2 8HW, Avon, England
[2] Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England
关键词
Alzheimer's disease; alpha-secretase; amyloid; apolipoprotein E; beta-secretase; BACE; choline acetyltransferase; TACE;
D O I
10.1016/S0006-291X(02)02635-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid plaque, a neuropathological hallmark of Alzheimer's disease, is produced by the deposition of beta-amyloid (Abeta) peptide, which is cleaved from Amyloid Precursor Protein (APP) by the enzyme beta-secretase. Only small amounts of Abeta form in normal brain; more typically this is precluded by the processing of APP by alpha-secretase. Here, we describe a decrease in alpha-secretase (81% of normal) and a large increase in beta-secretase activity (185%) in sporadic Alzheimer's disease temporal cortex. Since alpha-secretase is present principally in neurons known to be vulnerable in Alzheimer's disease, and there is known competition between alpha- and beta-secretase for the substrate APP, it is significant that the majority of Alzheimer samples tested here were low in a-secretase. Eighty percent of Alzheimer brains examined had an increase in beta-secretase, a decrease in alpha-secretase, or both; which may account for the means by which the majority of people develop Alzheimer's disease. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [1] Gamma secretase activating protein as profound target for alzheimer\'s disease
    Angira, Deekshi
    Thiruvenkatam, Vijay
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : C1187 - C1187
  • [2] γ-Secretase in Alzheimer’s disease
    Ji-Yeun Hur
    Experimental & Molecular Medicine, 2022, 54 : 433 - 446
  • [3] Changes in alpha- and beta-secretase in Alzheimer's disease
    Tyler, SJ
    Dawbarn, D
    Wilcock, GK
    Allen, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U103 - U103
  • [4] Qualitative changes in human γ-secretase underlie familial Alzheimer's disease
    Szaruga, Maria
    Veugelen, Sarah
    Benurwar, Manasi
    Lismont, Sam
    Sepulveda-Falla, Diego
    Lleo, Alberto
    Ryan, Natalie S.
    Lashley, Tammaryn
    Fox, Nick C.
    Murayama, Shigeo
    Gijsen, Harrie
    De Strooper, Bart
    Chavez-Gutierrez, Lucia
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (12): : 2003 - 2013
  • [5] γ-Secretase inhibitors and Alzheimer's disease
    Roberts, SB
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (12) : 1579 - 1588
  • [6] Targeting γ-secretase for Alzheimer's disease
    Wolfe, Michael S.
    Alzheimer: 100 Years and Beyond, 2006, : 265 - 268
  • [7] Secretase inhibitors for Alzheimer's disease
    Kornilova, AY
    Wolfe, MS
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 41 - 50
  • [8] β-secretase -: A target for Alzheimer's disease
    Citron, M
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 79 - 83
  • [9] Alzheimer's disease:: β-amyloid and γ-secretase
    Iwatsubo, Takeshi
    NEUROBIOLOGY OF AGING, 2008, 29 : S13 - S13
  • [10] Alzheimer's disease -: Closing in on γ-secretase
    De Strooper, B
    NATURE, 2000, 405 (6787) : 627 - 629